We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Ventana and Barco Alliance to Revolutionize Digital Pathology Viewing Experience

By LabMedica International staff writers
Posted on 14 Jun 2013
Print article
Ventana Medical Systems, Inc. (VMSI; Tucson, AZ, USA), member of the Roche Group, has announced the signing of a worldwide agreement with healthcare imaging expert Barco, Inc. (Kortrijk Belgium) to provide Barco's leading diagnostic and clinical review display systems for use with Ventana’s Virtuoso image and workflow management system, offering a turnkey solution that provides consistent whole slide image viewing with efficiency.

"This agreement represents a fusion of digital pathology visualization technologies from two of the industry's most innovative healthcare leaders," said Steve Burnell, PhD, digital pathology and workflow lifecycle leader at VMSI; "The Ventana integrated digital pathology solution, now including Barco's products, will appeal to the most discerning practitioners."

The advantages of medical grade displays over commercial off-the-shelf monitors include enhanced contrast; color accuracy and sharpness; prolonged image stability over time; and the ability to calibrate the screen for optimal viewing. Barco's Coronis Fusion 4MP DL diagnostic color display and MDRC-2124 wide-screen clinical monitor offer these capabilities and more for precise, high confidence viewing. Barco's system supports effortless and precise panning and zooming on whole slide images. Moreover, the display system includes Barco's MediCal Awe, an automated, real-time calibration system that provides high image quality and consistency across the screen for the life of the display.

Ventana’s Virtuoso is a comprehensive, web-based software application. From initial slide scanning to complete reporting, the Virtuoso software supports multiple users, enabling remote viewing of slide images, online collaboration sessions with other pathologists, and slide sharing of images. Its intuitive user interfaces are customized for the workflow of pathologists, histotechnologists, lab administrators, and clinicians, enhancing efficiencies throughout the process.

"We are delighted to forge this exciting alliance with Ventana as we solidify our ongoing commitment to the digital pathology market," said Mike Sklar, vice president sales, healthcare, at Barco, North America; "Ventana offers all the ingredients for a successful partnership: in-depth market knowledge, a passion for technology excellence, and unwavering dedication to customer needs—all of the tenets that Barco upholds."

Related Links:
Ventana Medical Systems
Medical Imaging Systems at Barco, Inc.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.